Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 17/20 | 0.38 |
| ▸ | BCL2 | P10415 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | BAD | Q92934 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2603513 | 0.90 | PDK2 (0.38) | CNR2MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL2603552 | 0.88 | CNR2 (0.38) | CNR2BCL2MCL1BADMEN1 | |
| SCHEMBL802009 | 0.87 | PDK2 (0.37) | CNR2MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL2603514 | 0.85 | PDK2 (0.38) | CNR2MEN1HTTKMT2ATDP1 | |
| SCHEMBL2603515 | 0.84 | PDK2 (0.38) | CNR2MEN1KMT2A | |
| SCHEMBL12116393 | 0.83 | BCL2 (0.39) | CNR2BCL2MCL1BADMEN1 | |
| SCHEMBL31853 | 0.83 | L3MBTL1 (0.32) | MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL2603567 | 0.83 | L3MBTL1 (0.35) | MEN1MAPTHTTKMT2AL3MBTL1 | |
| SCHEMBL802450 | 0.82 | PDK2 (0.38) | CNR2MEN1HTTKMT2ATDP1 | |
| SCHEMBL13285166 | 0.82 | ENPP2 (0.37) | CNR2BCL2MCL1BAD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9040172-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-05-26 | — | — | US | disclosed |
| US-9040172-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-05-26 | — | — | US | disclosed |
| US-20140299865-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-10-09 | — | — | US | disclosed |
| US-20140299865-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-10-09 | — | — | US | disclosed |
| US-20120097899-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-04-26 | — | — | US | disclosed |
| US-20120097899-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-04-26 | — | — | US | disclosed |
| WO-2011000455-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120097899-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SLCO4C1, ICMT, NUDC | CNR2 3952/4885BCL2 4765/4885MCL1 4722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.